BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 29719205)

  • 1. CXCR4 overexpression is correlated with poor prognosis in colorectal cancer.
    Xu C; Zheng L; Li D; Chen G; Gu J; Chen J; Yao Q
    Life Sci; 2018 Sep; 208():333-340. PubMed ID: 29719205
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stromal cell derived factor-1 and CXCR4 expression in colorectal cancer promote liver metastasis.
    Amara S; Chaar I; Khiari M; Ounissi D; Weslati M; Boughriba R; Hmida AB; Bouraoui S
    Cancer Biomark; 2015; 15(6):869-79. PubMed ID: 26406413
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of CXCR4 and SDF1 as prognostic factors for survival and the association with clinicopathology in colorectal cancer: A systematic meta-analysis.
    Li YP; Pang J; Gao S; Bai PY; Wang WD; Kong P; Cui Y
    Tumour Biol; 2017 Jun; 39(6):1010428317706206. PubMed ID: 28621237
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overexpression of both CXC chemokine receptor 4 and vascular endothelial growth factor proteins predicts early distant relapse in stage II-III colorectal cancer patients.
    Ottaiano A; Franco R; Aiello Talamanca A; Liguori G; Tatangelo F; Delrio P; Nasti G; Barletta E; Facchini G; Daniele B; Di Blasi A; Napolitano M; Ieranò C; Calemma R; Leonardi E; Albino V; De Angelis V; Falanga M; Boccia V; Capuozzo M; Parisi V; Botti G; Castello G; Vincenzo Iaffaioli R; Scala S
    Clin Cancer Res; 2006 May; 12(9):2795-803. PubMed ID: 16675573
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The association of CXCR4 expression with prognosis and clinicopathological indicators in colorectal carcinoma patients: a meta-analysis.
    Lv S; Yang Y; Kwon S; Han M; Zhao F; Kang H; Dai C; Wang R
    Histopathology; 2014 Apr; 64(5):701-12. PubMed ID: 24422942
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association between expression of vascular endothelial growth factor C, chemokine receptor CXCR4 and lymph node metastasis in colorectal cancer.
    Fukunaga S; Maeda K; Noda E; Inoue T; Wada K; Hirakawa K
    Oncology; 2006; 71(3-4):204-11. PubMed ID: 17641542
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes in CXCL12/CXCR4-chemokine expression during onset of colorectal malignancies.
    Oliveira Frick V; Rubie C; Ghadjar P; Faust SK; Wagner M; Gräber S; Schilling MK
    Tumour Biol; 2011 Feb; 32(1):189-96. PubMed ID: 20865359
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognosis and Clinicopathology of CXCR4 in Colorectal Cancer Patients: a Meta-analysis.
    Li LN; Jiang KT; Tan P; Wang AH; Kong QY; Wang CY; Lu HR; Wang J
    Asian Pac J Cancer Prev; 2015; 16(9):4077-80. PubMed ID: 25987090
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic and Predictive Role of CXC Chemokine Receptor 4 in Metastatic Colorectal Cancer Patients.
    Ottaiano A; Scala S; Normanno N; Botti G; Tatangelo F; Di Mauro A; Capozzi M; Facchini S; Tafuto S; Nasti G
    Appl Immunohistochem Mol Morphol; 2020; 28(10):755-760. PubMed ID: 31985548
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CXCR4 overexpression correlates with poor prognosis in myasthenia gravis-associated thymoma.
    Wang W; Liu D; Yang L; Li Y; Xu H; Wang F; Zhao J; Zhang L
    Hum Pathol; 2016 Mar; 49():49-53. PubMed ID: 26826409
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CXCR4 as a prognostic biomarker in gastrointestinal cancer: a meta-analysis.
    Jiang Q; Sun Y; Liu X
    Biomarkers; 2019 Sep; 24(6):510-516. PubMed ID: 31244335
    [No Abstract]   [Full Text] [Related]  

  • 12. Effect of chemokine receptors CXCR4 and CCR7 on the metastatic behavior of human colorectal cancer.
    Schimanski CC; Schwald S; Simiantonaki N; Jayasinghe C; Gönner U; Wilsberg V; Junginger T; Berger MR; Galle PR; Moehler M
    Clin Cancer Res; 2005 Mar; 11(5):1743-50. PubMed ID: 15755995
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is neuroendocrine differentiation a prognostic factor in poorly differentiated colorectal cancer?
    Chen Y; Liu F; Meng Q; Ma S
    World J Surg Oncol; 2017 Mar; 15(1):71. PubMed ID: 28351413
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CXCR4, CXCL12 and the relative CXCL12-CXCR4 expression as prognostic factors in colon cancer.
    Stanisavljević L; Aßmus J; Storli KE; Leh SM; Dahl O; Myklebust MP
    Tumour Biol; 2016 Jun; 37(6):7441-52. PubMed ID: 26678887
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD 133+ and CXCR4+ colon cancer cells as a marker for lymph node metastasis.
    Silinsky J; Grimes C; Driscoll T; Green H; Cordova J; Davis NK; Li L; Margolin DA
    J Surg Res; 2013 Nov; 185(1):113-8. PubMed ID: 23777983
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Loss of the metastasis suppressor gene KiSS1 is associated with lymph node metastasis and poor prognosis in human colorectal cancer.
    Okugawa Y; Inoue Y; Tanaka K; Toiyama Y; Shimura T; Okigami M; Kawamoto A; Hiro J; Saigusa S; Mohri Y; Uchida K; Kusunoki M
    Oncol Rep; 2013 Sep; 30(3):1449-54. PubMed ID: 23784200
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mismatch repair system and p53 expression in patients with T1 and T2 colorectal cancer: predictive role of lymph node metastasis and survival.
    Huh JW; Kim HC; Kim SH; Park YA; Cho YB; Yun SH; Lee WY; Chun HK
    J Surg Oncol; 2014 Jun; 109(8):848-52. PubMed ID: 24623275
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Relationship between E-CD and Snail expressions and tumor invasion, metastasis and prognosis in colorectal cancer].
    Zheng BA; Deng GL; Dong QJ; Zhao ZS; Deng YC
    Zhonghua Zhong Liu Za Zhi; 2010 Feb; 32(2):111-6. PubMed ID: 20403241
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High expression of C-X-C chemokine receptor 4 and Notch1 is predictive of lymphovascular invasion and poor prognosis in lung adenocarcinoma.
    Cong Z; Wu H; Guo Z; Qin T; Xu Y; Jing H; Wang Y; Shen Y
    Tumour Biol; 2017 Jun; 39(6):1010428317708698. PubMed ID: 28618922
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LGR5 and CD133 as prognostic and predictive markers for fluoropyrimidine-based adjuvant chemotherapy in colorectal cancer.
    Stanisavljević L; Myklebust MP; Leh S; Dahl O
    Acta Oncol; 2016 Dec; 55(12):1425-1433. PubMed ID: 27435662
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.